Current and Future Trends in the Treatment of Renal Cancer{A figure is presented}

Thomas Keane, David Gillatt, Christopher P Evans, Andrea Tubaro

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Kidney cancer, of which renal cell cancer (RCC) is the most common form, accounts for just under 2% of newly diagnosed malignancies worldwide. When detected early, surgery is the most efficacious treatment for patients with nonmetastatic, localised RCC, but for patients with large tumours, regional lymph node involvement, or inferior vena cava (IVC) tumour thrombus, complete tumour resection can be challenging and surgical resection alone is often insufficient to prevent disease recurrence. For patients who experience recurrence or develop metastatic disease, treatment options are limited and the prognosis is extremely poor. In this article, treatment options for different types of patients with RCC are deliberated. For patients with IVC tumour thrombus, the various approaches and use of embolisation are discussed. Immunotherapy and novel, targeted agents are examined as treatment options for patients with metastatic disease. For patients medically unsuitable for radical surgery, other alternatives including nephron-sparing surgery (partial nephrectomy, cryoablation, and radiofrequency ablation) and observation with supportive care are discussed.

Original languageEnglish (US)
Pages (from-to)374-384
Number of pages11
JournalEuropean Urology, Supplements
Volume6
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Kidney Neoplasms
Renal Cell Carcinoma
Inferior Vena Cava
Neoplasms
Therapeutics
Thrombosis
Recurrence
Cryosurgery
Nephrons
Nephrectomy
Immunotherapy
Lymph Nodes
Observation

Keywords

  • Immunotherapy
  • Inferior vena cava
  • Laparoscopic nephrectomy
  • Partial nephrectomy
  • Radical nephrectomy
  • Renal cell cancer
  • Renal metastases
  • Thrombus

ASJC Scopus subject areas

  • Urology

Cite this

Current and Future Trends in the Treatment of Renal Cancer{A figure is presented}. / Keane, Thomas; Gillatt, David; Evans, Christopher P; Tubaro, Andrea.

In: European Urology, Supplements, Vol. 6, No. 3, 03.2007, p. 374-384.

Research output: Contribution to journalArticle

Keane, Thomas ; Gillatt, David ; Evans, Christopher P ; Tubaro, Andrea. / Current and Future Trends in the Treatment of Renal Cancer{A figure is presented}. In: European Urology, Supplements. 2007 ; Vol. 6, No. 3. pp. 374-384.
@article{41af8dda4d8f42bf846901191d224cf3,
title = "Current and Future Trends in the Treatment of Renal Cancer{A figure is presented}",
abstract = "Kidney cancer, of which renal cell cancer (RCC) is the most common form, accounts for just under 2{\%} of newly diagnosed malignancies worldwide. When detected early, surgery is the most efficacious treatment for patients with nonmetastatic, localised RCC, but for patients with large tumours, regional lymph node involvement, or inferior vena cava (IVC) tumour thrombus, complete tumour resection can be challenging and surgical resection alone is often insufficient to prevent disease recurrence. For patients who experience recurrence or develop metastatic disease, treatment options are limited and the prognosis is extremely poor. In this article, treatment options for different types of patients with RCC are deliberated. For patients with IVC tumour thrombus, the various approaches and use of embolisation are discussed. Immunotherapy and novel, targeted agents are examined as treatment options for patients with metastatic disease. For patients medically unsuitable for radical surgery, other alternatives including nephron-sparing surgery (partial nephrectomy, cryoablation, and radiofrequency ablation) and observation with supportive care are discussed.",
keywords = "Immunotherapy, Inferior vena cava, Laparoscopic nephrectomy, Partial nephrectomy, Radical nephrectomy, Renal cell cancer, Renal metastases, Thrombus",
author = "Thomas Keane and David Gillatt and Evans, {Christopher P} and Andrea Tubaro",
year = "2007",
month = "3",
doi = "10.1016/j.eursup.2006.12.006",
language = "English (US)",
volume = "6",
pages = "374--384",
journal = "European Urology, Supplements",
issn = "1569-9056",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Current and Future Trends in the Treatment of Renal Cancer{A figure is presented}

AU - Keane, Thomas

AU - Gillatt, David

AU - Evans, Christopher P

AU - Tubaro, Andrea

PY - 2007/3

Y1 - 2007/3

N2 - Kidney cancer, of which renal cell cancer (RCC) is the most common form, accounts for just under 2% of newly diagnosed malignancies worldwide. When detected early, surgery is the most efficacious treatment for patients with nonmetastatic, localised RCC, but for patients with large tumours, regional lymph node involvement, or inferior vena cava (IVC) tumour thrombus, complete tumour resection can be challenging and surgical resection alone is often insufficient to prevent disease recurrence. For patients who experience recurrence or develop metastatic disease, treatment options are limited and the prognosis is extremely poor. In this article, treatment options for different types of patients with RCC are deliberated. For patients with IVC tumour thrombus, the various approaches and use of embolisation are discussed. Immunotherapy and novel, targeted agents are examined as treatment options for patients with metastatic disease. For patients medically unsuitable for radical surgery, other alternatives including nephron-sparing surgery (partial nephrectomy, cryoablation, and radiofrequency ablation) and observation with supportive care are discussed.

AB - Kidney cancer, of which renal cell cancer (RCC) is the most common form, accounts for just under 2% of newly diagnosed malignancies worldwide. When detected early, surgery is the most efficacious treatment for patients with nonmetastatic, localised RCC, but for patients with large tumours, regional lymph node involvement, or inferior vena cava (IVC) tumour thrombus, complete tumour resection can be challenging and surgical resection alone is often insufficient to prevent disease recurrence. For patients who experience recurrence or develop metastatic disease, treatment options are limited and the prognosis is extremely poor. In this article, treatment options for different types of patients with RCC are deliberated. For patients with IVC tumour thrombus, the various approaches and use of embolisation are discussed. Immunotherapy and novel, targeted agents are examined as treatment options for patients with metastatic disease. For patients medically unsuitable for radical surgery, other alternatives including nephron-sparing surgery (partial nephrectomy, cryoablation, and radiofrequency ablation) and observation with supportive care are discussed.

KW - Immunotherapy

KW - Inferior vena cava

KW - Laparoscopic nephrectomy

KW - Partial nephrectomy

KW - Radical nephrectomy

KW - Renal cell cancer

KW - Renal metastases

KW - Thrombus

UR - http://www.scopus.com/inward/record.url?scp=33846405692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846405692&partnerID=8YFLogxK

U2 - 10.1016/j.eursup.2006.12.006

DO - 10.1016/j.eursup.2006.12.006

M3 - Article

AN - SCOPUS:33846405692

VL - 6

SP - 374

EP - 384

JO - European Urology, Supplements

JF - European Urology, Supplements

SN - 1569-9056

IS - 3

ER -